AliveCor’s KardiaMobile 6L Receives FDA’s Clearance as Six-Lead Personal ECG Device

AliveCor’s KardiaMobile 6L Receives FDA’s Clearance as Six-Lead Personal ECG Device

Shots:

  • KardiaMobile is the personal ECG device delivering multi-dimensional insight into a patient’s heart, connected with the Kardia app used to detect AF, bradycardia, tachycardia, and normal rhythm in an ECG without using gels/wires
  • Kardia 6-lead smartphone ECG tracings can diagnose heart rhythm and conduction abnormalities which are leading indicators of cardiovascular disease and is expected to be available in Jun’19
  • The KardiaMobile six-lead device contains two electrodes on the top of the device & one on the bottom, placing their thumbs on two top electrodes with a bottom electrode is placed on left knee/ankle, forming Einthoven Triangle, providing better insights into electrical activity in the heart

Click here to read full press release/ article | Ref: PRNewsWire | Image: Research Gate